REVIEW
|
doi:10.20944/preprints202401.0426.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
PDAC; molecular alterations; oncogenic pathways; targeted therapy; preclinical; clinical; combinational therapy; clinical trials
Online: 5 January 2024 (06:28:11 CET)